Jetra Therapeutics develops new treatment for obesity-related liver disease designed to reduce stress in liver cells.
Jetra Therapeutics has raised $1.3M in total funding. The most recent round was Seed. The last funding was announced in October 2021.
Jetra Therapeutics's investors include IP Group Australia.
Jetra Therapeutics is headquartered in Brisbane, Australia.
Jetra Therapeutics develops new treatment for obesity-related liver disease designed to reduce stress in liver cells.
Jetra Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Jetra Therapeutics — Funding & Investors." VCBacked, October 20, 2021, https://www.vcbacked.co/company/jetra-therapeutics. Accessed August 14, 2026.
VCBacked. (2021). Jetra Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/jetra-therapeutics
{{cite web |title=Jetra Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/jetra-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated